Assyro AI

Orange Book product · Generic (ANDA)

SUGAMMADEX SODIUM

SUGAMMADEX SODIUM

Generic (ANDA)ANDA 214337TE APRX ASPIRO

At a glance

Jun 09, 2023

Approved

Generic (ANDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jun 09, 2023

    3 yr 1 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

SUGAMMADEX SODIUM

Strength

EQ 200MG BASE/2ML (EQ 100MG BASE/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

AP

Application

ANDA 214337

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of SUGAMMADEX SODIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.